Although 40-50% of AML cases do not carry any detectable chromosomal abnormalities, a fraction of them are found to have mutations of genes that normally function in cell proliferation, differentiation, and survival such as FLT3, NPM1, RAS, WT1, and AML1 [3,4]. Here, FLT3 is linked to acute myeloid leukemia.